Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90.84 CHF | -0.29% | -2.50% | +7.02% |
May. 27 | Novartis: positive phase III results in C3G | CF |
May. 27 | Novartis: presented results for kidney disease | CF |
Sales 2024 * | 49.05B 44.74B | Sales 2025 * | 51.11B 46.62B | Capitalization | 204B 186B |
---|---|---|---|---|---|
Net income 2024 * | 10.48B 9.56B | Net income 2025 * | 11.74B 10.71B | EV / Sales 2024 * | 4.41 x |
Net Debt 2024 * | 12.07B 11.01B | Net Debt 2025 * | 10.61B 9.68B | EV / Sales 2025 * | 4.2 x |
P/E ratio 2024 * |
18.7
x | P/E ratio 2025 * |
16.2
x | Employees | 76,057 |
Yield 2024 * |
3.61% | Yield 2025 * |
3.75% | Free-Float | 85.22% |
Latest transcript on Novartis AG
1 day | -0.44% | ||
1 week | -2.96% | ||
Current month | +2.31% | ||
1 month | +1.80% | ||
3 months | +1.23% | ||
6 months | +6.84% | ||
Current year | +7.35% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 04-12-31 | |
Director of Finance/CFO | 59 | 02-12-31 | |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 62 | 22-05-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bill Winters
BRD | Director/Board Member | 62 | 12-12-31 |
Simon Moroney
BRD | Director/Board Member | 65 | 20-02-27 |
Chairman | 68 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
10.40% | 121 M€ | -.--% | - | |
5.57% | 17 M€ | +7.15% | - | |
4.12% | 88 M€ | +10.37% | - | |
3.79% | 2 M€ | -25.75% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-29 | 90.83 | -0.31% | 636 613 |
24-05-28 | 91.11 | -1.00% | 2,322,194 |
24-05-27 | 92.03 | +0.32% | 1,193,903 |
24-05-24 | 91.74 | -1.11% | 2,520,278 |
24-05-23 | 92.77 | -0.42% | 2,925,320 |
Delayed Quote Swiss Exchange, May 28, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.35% | 204B | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B | |
-1.48% | 120B |
- Stock Market
- Equities
- NOVN Stock